MRNA vs VITL · rev $145.0M vs P/E 10, rev $353.2M
Moderna Inc (MRNA) versus Vital Farms Inc (VITL) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Vital Farms Inc (VITL) is a farm products company listed on NASDAQ.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported VITL revenue for 2026-06-28 was $353.2M. Net income was -$32.6M. Revenue was up 88.7% from 2026-03-29 to 2026-06-28. VITL currently screens at market cap $464.9M and trailing P/E 10.4.
MRNA currently screens at market cap $24.52B. VITL currently screens at market cap $464.9M and trailing P/E 10.4.
Not investment advice. Open the MRNA and VITL stock pages for the full models.
Not investment advice.